Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology

Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology

Cancer immunotherapy utilizes the immune system to fight cancer and has already moved from the laboratory to clinical application. However, and despite excellent therapeutic outcomes in some hematological and solid cancers, the regular clinical use of cancer immunotherapies reveals major limitations...

Full description

Bibliographic Details
Main Authors: Ernesto Bockamp, Sebastian Rosigkeit, Dominik Siegl, Detlef Schuppan
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cells
Subjects:
immune checkpoint inhibitor
CAR T cell therapy
bi-specific antibody therapy
tumor microenvironment
macrophage
myeloid derived suppressor cells (MDSC)
Online Access:https://www.mdpi.com/2073-4409/9/9/2102

Internet

https://www.mdpi.com/2073-4409/9/9/2102

Similar Items